Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |